Aurinia Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo® in Combination with Cabometyx® as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma Biotech Investing
Lexaria's DehydraTECH Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network Biotech Investing
Lexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network Biotech Investing
U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer Biotech Investing
ROSEN, SKILLED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
BriaCell Announces Closing of Over-Allotment Option in Connection with U.S. Public Offering, Bringing Total Gross Proceeds to US$28.7 Million Biotech Investing
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx Biotech Investing
BriaCell Therapeutics Presents Clinical Data at the American Association for Cancer Research Annual Meeting 2021 Biotech Investing
ROSEN, NATIONAL TRIAL LAWYERS, Encourages BELLUS Health Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BLU Biotech Investing
Neoadjuvant Opdivo Plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial Biotech Investing
